硫霉素的体外活性。
In vitro activity of thienamycin.
作者信息
Tally F P, Jacobus N V, Gorbach S L
出版信息
Antimicrob Agents Chemother. 1978 Sep;14(3):436-8. doi: 10.1128/AAC.14.3.436.
Abstract
The in vitro activity of thienamycin was tested against 135 aerobic and anaerobic bacteria. The compound was highly active against resistant gram-negative bacilli and penicillin-resistant Straphylococcus aureus. The antianaerobic spectrum of the drug seemed to be comparable to that of metronidazole.
摘要
对135种需氧菌和厌氧菌测试了硫霉素的体外活性。该化合物对耐药革兰氏阴性杆菌和耐青霉素金黄色葡萄球菌具有高度活性。该药的抗厌氧菌谱似乎与甲硝唑相当。
相似文献
1
In vitro activity of thienamycin.硫霉素的体外活性。
Antimicrob Agents Chemother. 1978 Sep;14(3):436-8. doi: 10.1128/AAC.14.3.436.
2
In vitro activity of N-formimidoyl thienamycin (MK0787).N-甲酰亚胺基硫霉素（MK0787）的体外活性
Antimicrob Agents Chemother. 1980 Oct;18(4):642-4. doi: 10.1128/AAC.18.4.642.
3
A comparative in vitro study of thienamycin.硫霉素的体外对比研究。
Infection. 1982 Jan;10(1):50-2. doi: 10.1007/BF01640839.
4
In vitro activity of thienamycin.硫霉素的体外活性。
Methods Find Exp Clin Pharmacol. 1981 Nov-Dec;3(6):387-90.
5
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.硫霉素的结晶衍生物N-甲脒基硫霉素（MK0787）的体外活性
Antimicrob Agents Chemother. 1980 Oct;18(4):557-61. doi: 10.1128/AAC.18.4.557.
6
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.硫霉素：具有强大广谱活性的新型β-内酰胺抗生素。
Antimicrob Agents Chemother. 1979 Apr;15(4):518-21. doi: 10.1128/AAC.15.4.518.
7
Comparative in vitro study of SQ26,776.SQ26,776的体外对比研究。
Antimicrob Agents Chemother. 1982 Feb;21(2):294-8. doi: 10.1128/AAC.21.2.294.
8
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.N-甲酰亚胺硫霉素和头孢菌素对医院获得性菌血症分离株的活性。
Antimicrob Agents Chemother. 1982 Mar;21(3):509-12. doi: 10.1128/AAC.21.3.509.
9
In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.N-甲酰亚胺硫霉素（MK0787）联合阿米卡星对革兰氏阴性杆菌和金黄色葡萄球菌的体外评价
Antimicrob Agents Chemother. 1982 Dec;22(6):1064-6. doi: 10.1128/AAC.22.6.1064.
10
Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.厌氧菌对N-甲酰亚胺基硫霉素（MK0787）及其他抗生素的敏感性。
Antimicrob Agents Chemother. 1982 Jun;21(6):1016-22. doi: 10.1128/AAC.21.6.1016.
引用本文的文献
1
An enantioselective formal synthesis of thienamycin.硫霉素的对映选择性形式合成。
Tetrahedron Lett. 2024 Jul 11;144. doi: 10.1016/j.tetlet.2024.155132. Epub 2024 Jun 8.
2
Amide Activation in Ground and Excited States.酰胺在基态和激发态中的活化。
Molecules. 2018 Nov 2;23(11):2859. doi: 10.3390/molecules23112859.
3
The evolving role of chemical synthesis in antibacterial drug discovery.化学合成在抗菌药物发现中不断演变的作用。
Angew Chem Int Ed Engl. 2014 Aug 18;53(34):8840-69. doi: 10.1002/anie.201310843. Epub 2014 Jul 2.
4
Carbapenems: past, present, and future.碳青霉烯类抗生素：过去、现在和未来。
Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. doi: 10.1128/AAC.00296-11. Epub 2011 Aug 22.
5
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.新型β-内酰胺类抗生素对厌氧菌的体外活性比较
Antimicrob Agents Chemother. 1981 Nov;20(5):600-9. doi: 10.1128/AAC.20.5.600.
6
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.硫霉素及相关碳青霉烯类抗生素在肾脏二肽酶即脱氢肽酶作用下的代谢
Antimicrob Agents Chemother. 1982 Jul;22(1):62-70. doi: 10.1128/AAC.22.1.62.
7
Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli.青霉烯衍生物：大肠杆菌中β-内酰胺酶稳定性及对青霉素结合蛋白的亲和力
Antimicrob Agents Chemother. 1982 Mar;21(3):492-7. doi: 10.1128/AAC.21.3.492.
8
A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.头孢西丁联合或不联合阿米卡星与克林霉素加阿米卡星治疗外科脓毒症的随机对照研究
Ann Surg. 1981 Mar;193(3):318-23. doi: 10.1097/00000658-198103000-00011.
9
In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.与头孢西丁、利福平、四环素及复方新诺明相比，N-甲酰亚胺基硫霉素对98株羊种布鲁氏菌临床分离株的体外活性。
Antimicrob Agents Chemother. 1982 Mar;21(3):501-3. doi: 10.1128/AAC.21.3.501.
10
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.N-甲酰亚胺硫霉素对革兰氏阳性和革兰氏阴性需氧及厌氧菌的体外比较活性及其β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Jan;21(1):180-7. doi: 10.1128/AAC.21.1.180.
本文引用的文献
1
Bacteroides fragilis resistant to the administration of clindamycin.脆弱拟杆菌对克林霉素给药耐药。
Am J Med. 1976 Mar;60(3):426-8. doi: 10.1016/0002-9343(76)90759-2.
2
Susceptibility of anaerobes to cefoxitin and other cephalosporins.厌氧菌对头孢西丁及其他头孢菌素的敏感性。
Antimicrob Agents Chemother. 1975 Feb;7(2):128-32. doi: 10.1128/AAC.7.2.128.
3
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.厌氧菌对23种抗菌剂的敏感性。
Antimicrob Agents Chemother. 1976 Oct;10(4):736-52. doi: 10.1128/AAC.10.4.736.
4
Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.头孢孟多及其他头孢菌素对需氧菌和厌氧菌的活性。
Antimicrob Agents Chemother. 1976 May;9(5):852-5. doi: 10.1128/AAC.9.5.852.
5
Binding of thienamycin and clavulanic acid to the penicillin-binding proteins of Escherichia coli K-12.硫霉素和克拉维酸与大肠杆菌K-12青霉素结合蛋白的结合。
Antimicrob Agents Chemother. 1977 Sep;12(3):406-9. doi: 10.1128/AAC.12.3.406.
6
Therapy for infections due to anaerobic bacteria: an overview.厌氧菌感染的治疗：概述
J Infect Dis. 1977 Mar;135 Suppl:S25-9. doi: 10.1093/infdis/135.supplement.s25.
Zotero 插件